{"transactions":[{"id":723247,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-30T20:05:19.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, representing the right to purchase 30,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted."}],"balance_after":20000,"derivative":{"exercise_price":29.82,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-26-026930","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126026930/form4.xml","form_type":"4"}},{"id":723246,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-30T20:05:19.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, representing the right to purchase 30,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted."}],"balance_after":25000,"derivative":{"exercise_price":29.82,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-26-026930","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126026930/form4.xml","form_type":"4"}},{"id":723245,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-30T20:05:19.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":45,"value":225000.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":75753,"source":{"system":"sec-edgar","filing":"0001140361-26-026930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126026930/form4.xml","form_type":"4"}},{"id":723244,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-30T20:05:19.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":29.82,"value":149100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":80753,"source":{"system":"sec-edgar","filing":"0001140361-26-026930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126026930/form4.xml","form_type":"4"}},{"id":723243,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-30T20:05:19.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":45,"value":225000.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":75753,"source":{"system":"sec-edgar","filing":"0001140361-26-026930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126026930/form4.xml","form_type":"4"}},{"id":723242,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-30T20:05:19.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":29.82,"value":149100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":80753,"source":{"system":"sec-edgar","filing":"0001140361-26-026930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126026930/form4.xml","form_type":"4"}},{"id":750248,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-04T20:05:24.000Z","date":"2026-06-02","kind":"exercise","planned":true,"acquired":true,"shares":4375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, representing the right to purchase 26,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 6, 2019, which was one quarter after the date on which the option was granted."}],"balance_after":1625,"derivative":{"exercise_price":16.66,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":4375},"source":{"system":"sec-edgar","filing":"0001140361-26-023988","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126023988/form4.xml","form_type":"4"}},{"id":750247,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-04T20:05:24.000Z","date":"2026-06-02","kind":"sale","planned":true,"acquired":false,"shares":4375,"price":35,"value":153125.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":75753,"source":{"system":"sec-edgar","filing":"0001140361-26-023988","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126023988/form4.xml","form_type":"4"}},{"id":750246,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-04T20:05:24.000Z","date":"2026-06-02","kind":"exercise","planned":true,"acquired":true,"shares":4375,"price":16.66,"value":72887.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":80128,"source":{"system":"sec-edgar","filing":"0001140361-26-023988","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126023988/form4.xml","form_type":"4"}},{"id":814950,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-06T20:05:42.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":true,"shares":3472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company."}],"balance_after":9132,"derivative":{"exercise_price":10.95,"expiration_date":"2028-08-20","underlying":"Common Stock","underlying_shares":3472},"source":{"system":"sec-edgar","filing":"0001140361-26-013334","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126013334/form4.xml","form_type":"4"}},{"id":814949,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-06T20:05:42.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":3472,"price":35,"value":121520.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":75556,"source":{"system":"sec-edgar","filing":"0001140361-26-013334","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126013334/form4.xml","form_type":"4"}},{"id":814948,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-06T20:05:42.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":true,"shares":3472,"price":10.95,"value":38018.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":79028,"source":{"system":"sec-edgar","filing":"0001140361-26-013334","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126013334/form4.xml","form_type":"4"}},{"id":880678,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-26T21:05:35.000Z","date":"2026-02-24","kind":"exercise","planned":false,"acquired":true,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The Fair Market Value of the vested derivative securities is $38.25 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest on February 22, 2027, and February 22, 2028, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"No expiration date for this type of award."}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001140361-26-006973","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006973/form4.xml","form_type":"4"}},{"id":880677,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-26T21:05:35.000Z","date":"2026-02-24","kind":"exercise","planned":false,"acquired":true,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest on February 22, 2027, and February 22, 2028, respectively. Upon the vesting of RSUs granted to the Reporting Person on February 22, 2024, the Reporting Person deferred the receipt of 1,500 shares of Common Stock and instead received 1,500 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest on February 22, 2027, and February 22, 2028, respectively. Upon the vesting of RSUs granted to the Reporting Person on February 22, 2024, the Reporting Person deferred the receipt of 1,500 shares of Common Stock and instead received 1,500 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"No expiration date for this type of award."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001140361-26-006973","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006973/form4.xml","form_type":"4"}},{"id":880676,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-26T21:05:35.000Z","date":"2026-02-24","kind":"exercise","planned":false,"acquired":true,"shares":3150,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The Fair Market Value of the vested derivative securities is $38.09 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 20, 2025. The remaining RSUs will vest on February 20, 2027, February 20, 2028, and February 20, 2029, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"No expiration date for this type of award."}],"balance_after":10500,"derivative":{"underlying":"Common Stock","underlying_shares":3150},"source":{"system":"sec-edgar","filing":"0001140361-26-006973","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006973/form4.xml","form_type":"4"}},{"id":880675,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-26T21:05:35.000Z","date":"2026-02-24","kind":"exercise","planned":false,"acquired":true,"shares":350,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 20, 2025. The remaining RSUs will vest on February 20, 2027, February 20, 2028, and February 20, 2029, respectively. Upon the vesting of RSUs granted to the Reporting Person on February 20, 2025, the Reporting Person deferred the receipt of 350 shares of Common Stock and instead received 350 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 20, 2025. The remaining RSUs will vest on February 20, 2027, February 20, 2028, and February 20, 2029, respectively. Upon the vesting of RSUs granted to the Reporting Person on February 20, 2025, the Reporting Person deferred the receipt of 350 shares of Common Stock and instead received 350 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"No expiration date for this type of award."}],"balance_after":13650,"derivative":{"underlying":"Common Stock","underlying_shares":350},"source":{"system":"sec-edgar","filing":"0001140361-26-006973","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006973/form4.xml","form_type":"4"}},{"id":880674,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:05:35.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":636,"price":38.25,"value":24327.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":75556,"source":{"system":"sec-edgar","filing":"0001140361-26-006973","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006973/form4.xml","form_type":"4"}},{"id":880673,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:05:35.000Z","date":"2026-02-24","kind":"exercise","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest on February 22, 2027, and February 22, 2028, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":76192,"source":{"system":"sec-edgar","filing":"0001140361-26-006973","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006973/form4.xml","form_type":"4"}},{"id":880672,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:05:35.000Z","date":"2026-02-24","kind":"exercise","planned":false,"acquired":true,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units (RSUs) converted to phantom stock units and are deferred under the Vericel Corporation Deferred Compensation Plan. The units will be payable only in shares of Common Stock upon the Reporting Person's elected Benefit Distribution Date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest on February 22, 2027, and February 22, 2028, respectively. Upon the vesting of RSUs granted to the Reporting Person on February 22, 2024, the Reporting Person deferred the receipt of 1,500 shares of Common Stock and instead received 1,500 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":74692,"source":{"system":"sec-edgar","filing":"0001140361-26-006973","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006973/form4.xml","form_type":"4"}},{"id":880671,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:05:35.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1335,"price":38.09,"value":50850.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":73192,"source":{"system":"sec-edgar","filing":"0001140361-26-006973","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006973/form4.xml","form_type":"4"}},{"id":880670,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:05:35.000Z","date":"2026-02-24","kind":"exercise","planned":false,"acquired":true,"shares":3150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 20, 2025. The remaining RSUs will vest on February 20, 2027, February 20, 2028, and February 20, 2029, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":74527,"source":{"system":"sec-edgar","filing":"0001140361-26-006973","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006973/form4.xml","form_type":"4"}},{"id":880669,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:05:35.000Z","date":"2026-02-24","kind":"exercise","planned":false,"acquired":true,"shares":350,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units (RSUs) converted to phantom stock units and are deferred under the Vericel Corporation Deferred Compensation Plan. The units will be payable only in shares of Common Stock upon the Reporting Person's elected Benefit Distribution Date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 20, 2025. The remaining RSUs will vest on February 20, 2027, February 20, 2028, and February 20, 2029, respectively. Upon the vesting of RSUs granted to the Reporting Person on February 20, 2025, the Reporting Person deferred the receipt of 350 shares of Common Stock and instead received 350 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":71377,"source":{"system":"sec-edgar","filing":"0001140361-26-006973","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006973/form4.xml","form_type":"4"}},{"id":891675,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-20T21:06:10.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 19, 2027. The remaining RSUs will vest in annual installments on February 19, 2028, February 19, 2029, and February 19, 2030, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"No expiration date for this type of award."}],"balance_after":14000,"derivative":{"underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001140361-26-006312","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006312/form4.xml","form_type":"4"}},{"id":891674,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T21:06:10.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"These options shall begin vesting on February 19, 2026 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period."}],"balance_after":35000,"derivative":{"exercise_price":38.17,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001140361-26-006312","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006312/form4.xml","form_type":"4"}},{"id":891673,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-20T21:06:10.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":2325,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Fair Market Value of the vested derivative securities is $37.41 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"No expiration date for this type of award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2325},"source":{"system":"sec-edgar","filing":"0001140361-26-006312","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006312/form4.xml","form_type":"4"}},{"id":891672,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-20T21:06:10.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest on February 17, 2027. Upon the vesting of RSUs granted to the Reporting Person on February 17, 2023, the Reporting Person deferred the receipt of 3,000 shares of Common Stock and instead received 3,000 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest on February 17, 2027. Upon the vesting of RSUs granted to the Reporting Person on February 17, 2023, the Reporting Person deferred the receipt of 3,000 shares of Common Stock and instead received 3,000 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"No expiration date for this type of award."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001140361-26-006312","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006312/form4.xml","form_type":"4"}},{"id":891671,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-20T21:06:10.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":982,"price":37.41,"value":36736.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":71027,"source":{"system":"sec-edgar","filing":"0001140361-26-006312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006312/form4.xml","form_type":"4"}},{"id":891670,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-20T21:06:10.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":2325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":72009,"source":{"system":"sec-edgar","filing":"0001140361-26-006312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006312/form4.xml","form_type":"4"}},{"id":891669,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-20T21:06:10.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units (RSUs) converted to phantom stock units and are deferred under the Vericel Corporation Deferred Compensation Plan. The units will be payable only in shares of Common Stock upon the Reporting Person's elected Benefit Distribution Date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest on February 17, 2027. Upon the vesting of RSUs granted to the Reporting Person on February 17, 2023, the Reporting Person deferred the receipt of 3,000 shares of Common Stock and instead received 3,000 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":69684,"source":{"system":"sec-edgar","filing":"0001140361-26-006312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126006312/form4.xml","form_type":"4"}},{"id":906170,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-13T21:05:40.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":122,"price":26.27,"value":3204.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":66684,"source":{"system":"sec-edgar","filing":"0001140361-26-005413","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036126005413/form5.xml","form_type":"5"}},{"id":980734,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-04T21:05:33.000Z","date":"2025-12-02","kind":"exercise","planned":true,"acquired":true,"shares":1652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, representing the right to purchase 48,750 shares, became exercisable in quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 11, 2020."}],"balance_after":7098,"derivative":{"exercise_price":18,"expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":1652},"source":{"system":"sec-edgar","filing":"0001140361-25-044348","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125044348/form4.xml","form_type":"4"}},{"id":980733,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-04T21:05:33.000Z","date":"2025-12-02","kind":"sale","planned":true,"acquired":false,"shares":1652,"price":39.14,"value":64659.28,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":66562,"source":{"system":"sec-edgar","filing":"0001140361-25-044348","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125044348/form4.xml","form_type":"4"}},{"id":980732,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-04T21:05:33.000Z","date":"2025-12-02","kind":"exercise","planned":true,"acquired":true,"shares":1652,"price":18,"value":29736.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":68214,"source":{"system":"sec-edgar","filing":"0001140361-25-044348","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125044348/form4.xml","form_type":"4"}},{"id":1050619,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:06:00.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, representing the right to purchase 48,750 shares, became exercisable in quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 11, 2020."}],"balance_after":8750,"derivative":{"exercise_price":18,"expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-25-033807","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125033807/form4.xml","form_type":"4"}},{"id":1050618,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-09-03T20:06:00.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":35.77,"value":357700.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":66363,"source":{"system":"sec-edgar","filing":"0001140361-25-033807","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125033807/form4.xml","form_type":"4"}},{"id":1050617,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-09-03T20:06:00.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":18,"value":180000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":76363,"source":{"system":"sec-edgar","filing":"0001140361-25-033807","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125033807/form4.xml","form_type":"4"}},{"id":1123725,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-04T20:05:57.000Z","date":"2025-06-02","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, representing the right to purchase 48,750 shares, became exercisable in quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 11, 2020."}],"balance_after":18750,"derivative":{"exercise_price":18,"expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-25-021415","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125021415/form4.xml","form_type":"4"}},{"id":1123724,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-06-04T20:05:57.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":40.09,"value":400900.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":66237,"source":{"system":"sec-edgar","filing":"0001140361-25-021415","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125021415/form4.xml","form_type":"4"}},{"id":1123723,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-06-04T20:05:57.000Z","date":"2025-06-02","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":18,"value":180000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":76237,"source":{"system":"sec-edgar","filing":"0001140361-25-021415","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125021415/form4.xml","form_type":"4"}},{"id":1224426,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-05T21:05:34.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, representing the right to purchase 48,750 shares, became exercisable in quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 11, 2020."}],"balance_after":28750,"derivative":{"exercise_price":18,"expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-25-007179","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125007179/form4.xml","form_type":"4"}},{"id":1224425,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:05:34.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":49.53,"value":495300.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":66101,"source":{"system":"sec-edgar","filing":"0001140361-25-007179","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125007179/form4.xml","form_type":"4"}},{"id":1224424,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:05:34.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":18,"value":180000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":76101,"source":{"system":"sec-edgar","filing":"0001140361-25-007179","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125007179/form4.xml","form_type":"4"}},{"id":1244280,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-26T21:05:23.000Z","date":"2025-02-24","kind":"exercise","planned":false,"acquired":true,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Fair Market Value of the vested derivative securities is $52.33 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"No expiration date for this type of award."}],"balance_after":9000,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001140361-25-006086","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125006086/form4.xml","form_type":"4"}},{"id":1244279,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-26T21:05:23.000Z","date":"2025-02-24","kind":"exercise","planned":false,"acquired":true,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively. Upon the vesting of RSUs granted to the Reporting Person on February 22, 2024, the Reporting Person deferred the receipt of 50% of the vested 3,000 shares of Common Stock and instead received 1,500 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively. Upon the vesting of RSUs granted to the Reporting Person on February 22, 2024, the Reporting Person deferred the receipt of 50% of the vested 3,000 shares of Common Stock and instead received 1,500 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"No expiration date for this type of award."}],"balance_after":10500,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001140361-25-006086","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125006086/form4.xml","form_type":"4"}},{"id":1244278,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-26T21:05:23.000Z","date":"2025-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":636,"price":52.33,"value":33281.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":66101,"source":{"system":"sec-edgar","filing":"0001140361-25-006086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125006086/form4.xml","form_type":"4"}},{"id":1244277,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-26T21:05:23.000Z","date":"2025-02-24","kind":"exercise","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":66737,"source":{"system":"sec-edgar","filing":"0001140361-25-006086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125006086/form4.xml","form_type":"4"}},{"id":1244276,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-26T21:05:23.000Z","date":"2025-02-24","kind":"exercise","planned":false,"acquired":true,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units (RSUs) converted to phantom stock units and are deferred under the Vericel Corporation Deferred Compensation Plan. The units will be payable only in shares of Common Stock upon the Reporting Person's elected Benefit Distribution Date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively. Upon the vesting of RSUs granted to the Reporting Person on February 22, 2024, the Reporting Person deferred the receipt of 50% of the vested 3,000 shares of Common Stock and instead received 1,500 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":65237,"source":{"system":"sec-edgar","filing":"0001140361-25-006086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125006086/form4.xml","form_type":"4"}},{"id":1250964,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-24T21:05:13.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 20, 2026. The remaining RSUs will vest in annual installments on February 20, 2027, February 20, 2028, and February 20, 2029, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"No expiration date for this type of award."}],"balance_after":14000,"derivative":{"underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001140361-25-005658","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125005658/form4.xml","form_type":"4"}},{"id":1250963,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-24T21:05:13.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options shall begin vesting on February 20, 2025 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period."}],"balance_after":35000,"derivative":{"exercise_price":54.31,"expiration_date":"2035-02-20","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001140361-25-005658","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125005658/form4.xml","form_type":"4"}},{"id":1257183,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-20T21:05:45.000Z","date":"2025-02-19","kind":"exercise","planned":false,"acquired":true,"shares":1750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The Fair Market Value of the vested derivative securities is $57.78 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"No expiration date for this type of award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001140361-25-005256","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125005256/form4.xml","form_type":"4"}},{"id":1257182,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-20T21:05:45.000Z","date":"2025-02-18","kind":"exercise","planned":false,"acquired":true,"shares":2325,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The Fair Market Value of the vested derivative securities is $57.28 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"No expiration date for this type of award."}],"balance_after":2325,"derivative":{"underlying":"Common Stock","underlying_shares":2325},"source":{"system":"sec-edgar","filing":"0001140361-25-005256","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125005256/form4.xml","form_type":"4"}},{"id":1257181,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-20T21:05:45.000Z","date":"2025-02-18","kind":"exercise","planned":false,"acquired":true,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2026, and February 17, 2027, respectively. Upon the vesting of RSUs granted to the Reporting Person on February 17, 2023, the Reporting Person deferred the receipt of 3,000 shares of Common Stock and instead received 3,000 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2026, and February 17, 2027, respectively. Upon the vesting of RSUs granted to the Reporting Person on February 17, 2023, the Reporting Person deferred the receipt of 3,000 shares of Common Stock and instead received 3,000 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"No expiration date for this type of award."}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001140361-25-005256","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125005256/form4.xml","form_type":"4"}},{"id":1257180,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-20T21:05:45.000Z","date":"2025-02-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":853,"price":57.78,"value":49286.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":63737,"source":{"system":"sec-edgar","filing":"0001140361-25-005256","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125005256/form4.xml","form_type":"4"}},{"id":1257179,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-20T21:05:45.000Z","date":"2025-02-19","kind":"exercise","planned":false,"acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":64590,"source":{"system":"sec-edgar","filing":"0001140361-25-005256","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125005256/form4.xml","form_type":"4"}},{"id":1257178,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-20T21:05:45.000Z","date":"2025-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":985,"price":57.28,"value":56420.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":62840,"source":{"system":"sec-edgar","filing":"0001140361-25-005256","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125005256/form4.xml","form_type":"4"}},{"id":1257177,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-20T21:05:45.000Z","date":"2025-02-18","kind":"exercise","planned":false,"acquired":true,"shares":2325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest on February 18, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":63825,"source":{"system":"sec-edgar","filing":"0001140361-25-005256","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125005256/form4.xml","form_type":"4"}},{"id":1257176,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-20T21:05:45.000Z","date":"2025-02-18","kind":"exercise","planned":false,"acquired":true,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units (RSUs) converted to phantom stock units and are deferred under the Vericel Corporation Deferred Compensation Plan. The units will be payable only in shares of Common Stock upon the Reporting Person's elected Benefit Distribution Date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2026, and February 17, 2027, respectively. Upon the vesting of RSUs granted to the Reporting Person on February 17, 2023, the Reporting Person deferred the receipt of 3,000 shares of Common Stock and instead received 3,000 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":61500,"source":{"system":"sec-edgar","filing":"0001140361-25-005256","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125005256/form4.xml","form_type":"4"}},{"id":1270331,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-13T21:05:25.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":129,"price":34.04,"value":4391.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":58500,"source":{"system":"sec-edgar","filing":"0001140361-25-004298","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036125004298/form5.xml","form_type":"5"}},{"id":1346021,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-03T21:05:13.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, representing the right to purchase 26,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 6, 2019, which was one quarter after the date on which the option was granted."}],"balance_after":6000,"derivative":{"exercise_price":16.66,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-24-048294","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124048294/form4.xml","form_type":"4"}},{"id":1346020,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-03T21:05:13.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":58.72,"value":587200.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":58371,"source":{"system":"sec-edgar","filing":"0001140361-24-048294","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124048294/form4.xml","form_type":"4"}},{"id":1346019,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-03T21:05:13.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":16.66,"value":166600.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":68371,"source":{"system":"sec-edgar","filing":"0001140361-24-048294","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124048294/form4.xml","form_type":"4"}},{"id":1414633,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-05T20:05:37.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company."}],"balance_after":12604,"derivative":{"exercise_price":10.95,"expiration_date":"2028-08-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-24-040225","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124040225/form4.xml","form_type":"4"}},{"id":1414632,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-09-05T20:05:37.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":49.83,"value":498300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":58229,"source":{"system":"sec-edgar","filing":"0001140361-24-040225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124040225/form4.xml","form_type":"4"}},{"id":1414631,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-09-05T20:05:37.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":10.95,"value":109500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":68229,"source":{"system":"sec-edgar","filing":"0001140361-24-040225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124040225/form4.xml","form_type":"4"}},{"id":1507920,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-21T20:07:32.000Z","date":"2024-05-20","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company."}],"balance_after":22604,"derivative":{"exercise_price":10.95,"expiration_date":"2028-08-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-24-027027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124027027/form4.xml","form_type":"4"}},{"id":1507919,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-05-21T20:07:32.000Z","date":"2024-05-20","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":49.99,"value":499900.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":58116,"source":{"system":"sec-edgar","filing":"0001140361-24-027027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124027027/form4.xml","form_type":"4"}},{"id":1507918,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-05-21T20:07:32.000Z","date":"2024-05-20","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":10.95,"value":109500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":68116,"source":{"system":"sec-edgar","filing":"0001140361-24-027027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124027027/form4.xml","form_type":"4"}},{"id":1620626,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-26T21:05:36.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 22, 2025. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"No expiration date for this type of award."}],"balance_after":12000,"derivative":{"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001140361-24-009486","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124009486/form4.xml","form_type":"4"}},{"id":1620625,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T21:05:36.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options shall begin vesting on February 22, 2024 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period."}],"balance_after":30000,"derivative":{"exercise_price":48.31,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-24-009486","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124009486/form4.xml","form_type":"4"}},{"id":1626638,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T21:06:22.000Z","date":"2024-02-20","kind":"exercise","planned":false,"acquired":true,"shares":1750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Fair Market Value of the vested derivative securities is $49.50 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest on February 19, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"No expiration date for this type of award."}],"balance_after":1750,"derivative":{"underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001140361-24-009025","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124009025/form4.xml","form_type":"4"}},{"id":1626637,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T21:06:22.000Z","date":"2024-02-20","kind":"exercise","planned":false,"acquired":true,"shares":2325,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Fair Market Value of the vested derivative securities is $49.50 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2025, and February 18, 2026, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"No expiration date for this type of award."}],"balance_after":4650,"derivative":{"underlying":"Common Stock","underlying_shares":2325},"source":{"system":"sec-edgar","filing":"0001140361-24-009025","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124009025/form4.xml","form_type":"4"}},{"id":1626636,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T21:06:22.000Z","date":"2024-02-20","kind":"exercise","planned":false,"acquired":true,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Fair Market Value of the vested derivative securities is $49.50 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"No expiration date for this type of award."}],"balance_after":9000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001140361-24-009025","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124009025/form4.xml","form_type":"4"}},{"id":1626635,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-22T21:06:22.000Z","date":"2024-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":742,"price":49.5,"value":36729.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":57953,"source":{"system":"sec-edgar","filing":"0001140361-24-009025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124009025/form4.xml","form_type":"4"}},{"id":1626634,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-22T21:06:22.000Z","date":"2024-02-20","kind":"exercise","planned":false,"acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest on February 19, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":58695,"source":{"system":"sec-edgar","filing":"0001140361-24-009025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124009025/form4.xml","form_type":"4"}},{"id":1626633,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-22T21:06:22.000Z","date":"2024-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":985,"price":49.5,"value":48757.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":56945,"source":{"system":"sec-edgar","filing":"0001140361-24-009025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124009025/form4.xml","form_type":"4"}},{"id":1626632,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-22T21:06:22.000Z","date":"2024-02-20","kind":"exercise","planned":false,"acquired":true,"shares":2325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2025, and February 18, 2026, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":57930,"source":{"system":"sec-edgar","filing":"0001140361-24-009025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124009025/form4.xml","form_type":"4"}},{"id":1626631,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-22T21:06:22.000Z","date":"2024-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1379,"price":49.5,"value":68260.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":55605,"source":{"system":"sec-edgar","filing":"0001140361-24-009025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124009025/form4.xml","form_type":"4"}},{"id":1626630,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-22T21:06:22.000Z","date":"2024-02-20","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":56984,"source":{"system":"sec-edgar","filing":"0001140361-24-009025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124009025/form4.xml","form_type":"4"}},{"id":1647440,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-13T21:06:01.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":true,"shares":1625,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Fair Market Value of the vested derivative securities is $47.42 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of the Restricted Stock Units (RSUs) granted to the Reporting Person on February 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"No expiration date for this type of award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1625},"source":{"system":"sec-edgar","filing":"0001140361-24-007424","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124007424/form4.xml","form_type":"4"}},{"id":1647439,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-13T21:06:01.000Z","date":"2024-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":775,"price":47.42,"value":36750.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":53984,"source":{"system":"sec-edgar","filing":"0001140361-24-007424","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124007424/form4.xml","form_type":"4"}},{"id":1647438,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-13T21:06:01.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":true,"shares":1625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of the Restricted Stock Units (RSUs) granted to the Reporting Person on February 11, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":54759,"source":{"system":"sec-edgar","filing":"0001140361-24-007424","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036124007424/form4.xml","form_type":"4"}},{"id":1731831,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T21:05:43.000Z","date":"2023-11-20","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company."}],"balance_after":32604,"derivative":{"exercise_price":10.95,"expiration_date":"2028-08-20","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-23-054439","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036123054439/form4.xml","form_type":"4"}},{"id":1731830,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-11-22T21:05:43.000Z","date":"2023-11-20","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":36.4,"value":182000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":53007,"source":{"system":"sec-edgar","filing":"0001140361-23-054439","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036123054439/form4.xml","form_type":"4"}},{"id":1731829,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-11-22T21:05:43.000Z","date":"2023-11-20","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":10.95,"value":54750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":58007,"source":{"system":"sec-edgar","filing":"0001140361-23-054439","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000114036123054439/form4.xml","form_type":"4"}},{"id":2001451,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-23T01:57:40.000Z","date":"2023-02-19","kind":"exercise","acquired":false,"shares":1750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The Fair Market Value of the vested derivative securities is $29.82 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest in annual\ninstallments on February 19, 2024 and February 19, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"No expiration date for this type of award."}],"balance_after":3500,"derivative":{"underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001127602-23-006586","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223006586/form4.xml","form_type":"4"}},{"id":2001450,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-23T01:57:40.000Z","date":"2023-02-18","kind":"exercise","acquired":false,"shares":2325,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The Fair Market Value of the vested derivative securities is $29.82 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in\nannual installments on February 18, 2024, February 18, 2025, and February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"No expiration date for this type of award."}],"balance_after":6975,"derivative":{"underlying":"Common Stock","underlying_shares":2325},"source":{"system":"sec-edgar","filing":"0001127602-23-006586","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223006586/form4.xml","form_type":"4"}},{"id":2001449,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-23T01:57:40.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 17, 2024. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"No expiration date for this type of award."}],"balance_after":12000,"derivative":{"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001127602-23-006586","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223006586/form4.xml","form_type":"4"}},{"id":2001448,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option\n          (Right to Buy)","published_at":"2023-02-23T01:57:40.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options shall begin vesting on February 17, 2023 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period."}],"balance_after":28125,"derivative":{"exercise_price":29.82,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":28125},"source":{"system":"sec-edgar","filing":"0001127602-23-006586","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223006586/form4.xml","form_type":"4"}},{"id":2001447,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option\n          (Right to Buy)","published_at":"2023-02-23T01:57:40.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options shall begin vesting on February 17, 2023 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period."}],"balance_after":1875,"derivative":{"exercise_price":29.82,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001127602-23-006586","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223006586/form4.xml","form_type":"4"}},{"id":2001446,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-23T01:57:40.000Z","date":"2023-02-19","kind":"tax_withholding","acquired":false,"shares":752,"price":29.82,"value":22424.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":52412,"source":{"system":"sec-edgar","filing":"0001127602-23-006586","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223006586/form4.xml","form_type":"4"}},{"id":2001445,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-23T01:57:40.000Z","date":"2023-02-19","kind":"exercise","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest in annual\ninstallments on February 19, 2024 and February 19, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":53164,"source":{"system":"sec-edgar","filing":"0001127602-23-006586","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223006586/form4.xml","form_type":"4"}},{"id":2001444,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-23T01:57:40.000Z","date":"2023-02-18","kind":"tax_withholding","acquired":false,"shares":1108,"price":29.82,"value":33040.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":51414,"source":{"system":"sec-edgar","filing":"0001127602-23-006586","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223006586/form4.xml","form_type":"4"}},{"id":2001443,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-23T01:57:40.000Z","date":"2023-02-18","kind":"exercise","acquired":true,"shares":2325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in\nannual installments on February 18, 2024, February 18, 2025, and February 18, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":52522,"source":{"system":"sec-edgar","filing":"0001127602-23-006586","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223006586/form4.xml","form_type":"4"}},{"id":2017799,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-14T21:09:13.000Z","date":"2023-02-11","kind":"exercise","acquired":false,"shares":1625,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Fair Market Value of the vested derivative securities is $29.30 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 11, 2020. The remaining RSUs will vest on February 11, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"No expiration date for this type of award."}],"balance_after":1625,"derivative":{"underlying":"Common Stock","underlying_shares":1625},"source":{"system":"sec-edgar","filing":"0001127602-23-005118","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223005118/form4.xml","form_type":"4"}},{"id":2017798,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-14T21:09:13.000Z","date":"2023-02-11","kind":"tax_withholding","acquired":false,"shares":840,"price":29.3,"value":24612.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":50197,"source":{"system":"sec-edgar","filing":"0001127602-23-005118","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223005118/form4.xml","form_type":"4"}},{"id":2017797,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-14T21:09:13.000Z","date":"2023-02-11","kind":"exercise","acquired":true,"shares":1625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 11, 2020. The remaining RSUs will vest on February 11, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":51037,"source":{"system":"sec-edgar","filing":"0001127602-23-005118","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223005118/form4.xml","form_type":"4"}},{"id":2027158,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-08T21:05:27.000Z","date":"2023-02-06","kind":"exercise","acquired":false,"shares":650,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Fair Market Value of the vested derivative securities is $30.60 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 6, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"No expiration date for this type of award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":650},"source":{"system":"sec-edgar","filing":"0001127602-23-003988","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223003988/form4.xml","form_type":"4"}},{"id":2027157,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-08T21:05:27.000Z","date":"2023-02-06","kind":"tax_withholding","acquired":false,"shares":310,"price":30.6,"value":9486.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":49412,"source":{"system":"sec-edgar","filing":"0001127602-23-003988","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223003988/form4.xml","form_type":"4"}},{"id":2027156,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-08T21:05:27.000Z","date":"2023-02-06","kind":"exercise","acquired":true,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 6, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":49722,"source":{"system":"sec-edgar","filing":"0001127602-23-003988","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887359/000112760223003988/form4.xml","form_type":"4"}},{"id":2357034,"issuer":{"id":4481,"kind":"organization","name":"Vericel Corp"},"owners":[{"id":34611,"kind":"person","name":"Hopper Jonathan Mark","position":1,"cik":"0001626325","reported_name":"Hopper Jonathan Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-03T21:06:20.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options, representing the right to purchase 48,750 shares, became exercisable in quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 11, 2020."}],"balance_after":38750,"derivative":{"exercise_price":18,"expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001593968-22-000613","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/887359/000159396822000613/primary_01.xml","form_type":"4"}}],"next_cursor":"2022-03-03T21:06:20.000000Z,2357034"}